United Therapeutics (UTHR) Enters Agreement with DEKA R&D for Remodulin Delivery Development
Tweet Send to a Friend
United Therapeutics (NASDAQ: UTHR) announced the signing of an agreement with DEKA Research & Development Corp. for the development of ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
